Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific'

Caption: Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

Credit: Market Research Reports, Inc.

Related Press Releases

Non-Small Cell Lung Cancer Market in Asia-Pacific to Hit $4.9 Billion by 2022; Finds New Report

Link to this Photo

Email & IM:

Direct Link:

HTML Code:

IMG Code:

Download Photo

Photo Information

Release date:
Wednesday Jun 1, 2016

Release time:
02:50 am

Width::
997px

Height::
738px

Size::
404 KB

Share